Shares of Dentsply Sirona Inc. (XRAY) plummeted in pre-market trading on Wednesday, falling as much as 5.13% after the dental products giant slashed its full-year revenue and earnings guidance for 2024.

While Dentsply Sirona reported better-than-expected third-quarter earnings of $0.50 per share, topping analysts' estimates of $0.47, the company lowered its outlook for the full fiscal year, citing several headwinds.

For 2024, Dentsply Sirona now expects net sales in the range of $3.79 billion to $3.83 billion, down from its previous guidance of $3.86 billion to $3.90 billion. The company also cut its adjusted earnings per share forecast to $1.82 to $1.86, compared to the earlier range of $1.96 to $2.02.